General and Central Obesity, Combined Oral Contraceptive Use and Hypertension in Chinese Women

Background Asians have different body fat distributions and disease characteristics compared with Caucasians. The purpose of this study was to evaluate general and central obesity, combined oral contraceptive (COC) use, and their joint effects on the risk of hypertension in Chinese women. Methods A...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of hypertension Vol. 24; no. 12; pp. 1324 - 1330
Main Authors Wang, Chun, Li, Ying, Bai, Jianling, Qian, Weichong, Zhou, Jian, Sun, Zhiming, Ba, Lei, Wei, Wei, Li, Huiqiao, Sun, Tao
Format Journal Article
LanguageEnglish
Published Basingstoke Oxford University Press 01.12.2011
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background Asians have different body fat distributions and disease characteristics compared with Caucasians. The purpose of this study was to evaluate general and central obesity, combined oral contraceptive (COC) use, and their joint effects on the risk of hypertension in Chinese women. Methods A case-control study including 1,760 women (878 hypertensive cases and 882 normotensive controls) was conducted in China. Body weight, height, waist circumference (WC), blood pressure, serum lipids, and apolipoproteins were measured. History of contraceptive use and relevant factors were investigated. Odds ratio (OR) with 95% confidence interval (CI) was estimated for hypertension-related factors under unconditional logistic regression model. Results Our study showed that increased body mass index (BMI), increased WC, and COC use were risk factors for hypertension with an OR (95% CI) of 2.19 (1.69-2.83), 1.46 (1.13-1.88), and 1.26 (1.02-1.56), respectively. Compared with WC, BMI was more strongly associated with hypertension risk (OR 3.40, 95% CI 2.28-5.05, for highest vs. lowest quartile) and was a better predictor for blood pressure. COC users had a 1.39-fold (OR 1.39, 95% CI 1.14-1.69) increased risk compared with the nonusers, while stopping COC was associated with a 36% reduced risk (OR 0.64, 95% CI 0.42-0.98). The risk increased dramatically in combination of COC use with a BMI ≥28 kg/m2 or WC ≥90 cm (OR 8.02, 95% CI 5.05-12.74; OR 5.76, 95% CI 3.65-9.12, respectively). Conclusions General and central obesity, COC use, and their joint effects significantly increased the risk of hypertension in Chinese women. American Journal of Hypertension, advance online publication 1 September 2011; doi:10.1038/ajh.2011.157
ISSN:0895-7061
1879-1905
1941-7225
DOI:10.1038/ajh.2011.157